Universal CORP /VA/

Market Movers (8-K)

NYSE
Universal Corporation filed an amendment detailing the compensation package for its new Senior Vice President and Chief Financial Officer, Steven S. Diel.
NYSE
Universal Corporation announced its third-quarter and nine-month financial results for fiscal year 2026, alongside the appointment of Steven S. Diel as its new Senior Vice President and Chief Financial Officer.
Worse than expected
NYSE
Universal Corporation announced the appointment of Anubhav Mittal as its new Senior Vice President and Chief Financial Officer, effective February 17, 2026.
NYSE
Universal Corporation has entered into a new $1.4 billion unsecured credit agreement, replacing its existing facility and extending maturities for enhanced financial flexibility.
Capital raise
NYSE
Universal Corporation announced its second quarter and first half fiscal year 2026 financial results, alongside the appointment of Gregory A. Trojan to its Board of Directors.
Better than expected
NYSE
Universal Corporation reported a significant increase in first-quarter operating income and net income, driven by a favorable product mix in its Tobacco Operations segment.
Better than expected

Quarterly Earnings (10-Q)

NYSE
Universal Corporation reported a significant drop in net income and EPS for the quarter ended December 31, 2025, driven by lower tobacco sales and challenges in its ingredients segment.
Worse than expected
Capital raise
NYSE
Universal Corporation reports increased net income and diluted EPS for Q2 and H1 FY26, driven by solid Tobacco Operations, despite challenges in Ingredients and higher operating costs.
NYSE
Universal Corporation reported a significant increase in net income and diluted EPS for the first fiscal quarter of 2026, driven by strong performance in its Tobacco Operations segment.
Better than expected
NYSE
Universal Corporation's Q3 2025 results show a significant increase in revenue and operating income, primarily driven by strong tobacco sales volumes and prices.
Delay expected
Better than expected
NYSE
Universal Corporation's Q2 and first half of fiscal year 2025 saw revenue and operating income increases, primarily driven by strong tobacco sales volumes and prices.
Better than expected
Delay expected
NYSE
Universal Corporation's first quarter of fiscal year 2025 saw a significant increase in revenue and operating income, driven by strong demand in both its Tobacco and Ingredients segments.
Better than expected

Annual Reports (10-K)

NYSE
Universal Corporation reported a significant decrease in net income for fiscal year 2026, primarily due to a goodwill impairment charge and increased tobacco inventory write-downs.
Worse than expected
NYSE
Universal Corporation announced a 7% increase in consolidated revenues and a 5% rise in operating income for fiscal year 2025, driven by strong performance in both its Tobacco and Ingredients segments, despite a 21% drop in diluted earnings per share and the identification of a new material weakness in internal controls.
Worse than expected
NYSE
Universal Corporation amends its annual report on Form 10-K to reflect a material weakness in internal control over financial reporting related to an embezzlement at its Mozambique subsidiary.
Worse than expected
NYSE
Universal Corporation reports a strong fiscal year 2024 driven by its tobacco business, while making significant investments in its plant-based ingredients platform.
Better than expected

Insider Trading (Form 4)

NYSE
Universal Corp Director Robert C. Sledd reported a transaction involving the purchase of 2,845 shares of common stock.
NYSE
Universal Corp VP and Controller Scott J. Bleicher reported the acquisition of restricted stock units and the vesting of performance shares.
NYSE
Tatiana Santos Godoi, Chief Human Resources Officer of Universal Corp, was granted 2,515 restricted stock units.
NYSE
Senior VP McKeen Starke reports the vesting of performance shares and receipt of restricted stock units at Universal Corp.
NYSE
John Patrick O'Keefe, VP of Ingredients at Universal Corp, reported the vesting of performance shares and a related tax withholding transaction.
NYSE
Catherine H. Claiborne, VP and General Counsel of Universal Corp, reported the vesting of performance shares and a new restricted stock unit award.

Proxy Statements (Def-14A)

NYSE
Universal Corporation filed an amended Definitive Proxy Statement solely to replace an inadvertently filed incorrect sample proxy card, with no changes to the main body of the original Proxy Statement.
NYSE
Universal Corporation announced a remarkable fiscal year 2025 with increased revenue and operating income, a 55th consecutive annual dividend increase, and a strategic shift towards organic growth in its plant-based ingredients business, despite a decline in GAAP net income due to specific charges.
Better than expected
NYSE
Universal Corporation's proxy statement outlines key proposals for the upcoming annual shareholder meeting, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor.

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management has reported a beneficial ownership of 5.02% in Universal Corp/VA's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 1,781,041 shares, representing 7.14% of Universal Corp/VA's common stock, as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Universal Corp/VA following an internal realignment.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.0% beneficial ownership stake in Universal Corp /VA/ as of March 31, 2025.
NYSE
State Street Corporation has filed a Schedule 13G, reporting a 5% beneficial ownership stake in Universal Corp/VA's common stock as of December 31, 2024.